ANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024, at 8:30 a.m. ET
31 Julio 2024 - 6:00AM
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP)
today announced that the Company will release its second quarter
2024 financial results on Tuesday, August 6, 2024, prior to the
market open.
Nikhil Lalwani, President and Chief Executive Officer, and
Stephen P. Carey, Senior Vice President, Finance, and Chief
Financial Officer, will host a conference call to discuss the
results as follows:
Date |
Tuesday,
August 6, 2024 |
|
|
Time |
8:30 a.m. ET |
|
|
Toll free (U.S.) |
800-245-3047 |
|
|
Conference ID |
4619279 |
|
|
Webcast (live and replay) |
www.anipharmaceuticals.com, under the “Investors” section |
|
|
A replay of the conference call will be available within two
hours of the call’s completion and will remain accessible for two
weeks by dialing 800-753-5212 and entering access code 4619279.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified
biopharmaceutical company serving patients in need by developing,
manufacturing, and marketing high-quality branded and generic
prescription pharmaceutical products, including for diseases with
high unmet medical need. The Company is focused on delivering
sustainable growth by scaling up its Rare Disease business through
its lead asset Purified Cortrophin® Gel, strengthening its
Generics business with enhanced research and development
capabilities, delivering innovation in Established Brands, and
leveraging its U.S. based manufacturing footprint. For more
information, visit www.anipharmaceuticals.com.
Investor Relations Contact:Lisa M. Wilson,
In-Site Communications, Inc.212-452-2793lwilson@insitecony.com
SOURCE: ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals (NASDAQ:ANIP)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
ANI Pharmaceuticals (NASDAQ:ANIP)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025